DAFNA Capital Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-12,528
| Closed | -$328K | – | 81 |
|
|
2017
Q1 | $328K | Hold |
12,528
| – | – | 0.28% | 61 |
|
|
2016
Q4 | $222K | Hold |
12,528
| – | – | 0.2% | 60 |
|
|
2016
Q3 | $296K | Buy |
+12,528
| New | +$296K | 0.21% | 62 |
|
|
2016
Q2 | – | Sell |
-30,000
| Closed | -$1.33M | – | 104 |
|
|
2016
Q1 | $1.33M | Hold |
30,000
| – | – | 1.14% | 28 |
|
|
2015
Q4 | $1.64M | Hold |
30,000
| – | – | 1.46% | 21 |
|
|
2015
Q3 | $1.26M | Hold |
30,000
| – | – | 1.25% | 26 |
|
|
2015
Q2 | $1.56M | Buy |
+30,000
| New | +$1.56M | 1.32% | 27 |
|